BioMed Realty Trust, Inc. (BMR) Tops Q2 FFO by 2c
After the close, BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.41, $0.02 better than the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
